- Home
- PRE vs STTK Comparison
PRE vs STTK Comparison
Compare PRE & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- STTK
- Stock Information
- Founded
- PRE 2014
- STTK 2016
- Country
- PRE Hong Kong
- STTK United States
- Employees
- PRE N/A
- STTK N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- STTK Health Care
- Exchange
- PRE Nasdaq
- STTK Nasdaq
- Market Cap
- PRE 102.7M
- STTK 83.8M
- IPO Year
- PRE N/A
- STTK 2020
- Fundamental
- Price
- PRE $10.08
- STTK $1.92
- Analyst Decision
- PRE Buy
- STTK Hold
- Analyst Count
- PRE 1
- STTK 6
- Target Price
- PRE $9.00
- STTK $2.67
- AVG Volume (30 Days)
- PRE 70.0K
- STTK 1.6M
- Earning Date
- PRE 09-12-2025
- STTK 08-14-2025
- Dividend Yield
- PRE N/A
- STTK N/A
- EPS Growth
- PRE N/A
- STTK N/A
- EPS
- PRE N/A
- STTK N/A
- Revenue
- PRE $57,051,000.00
- STTK $2,997,000.00
- Revenue This Year
- PRE $198.17
- STTK N/A
- Revenue Next Year
- PRE $59.73
- STTK N/A
- P/E Ratio
- PRE N/A
- STTK N/A
- Revenue Growth
- PRE 151.74
- STTK N/A
- 52 Week Low
- PRE $3.10
- STTK $0.69
- 52 Week High
- PRE $11.99
- STTK $3.95
- Technical
- Relative Strength Index (RSI)
- PRE 66.67
- STTK 72.13
- Support Level
- PRE $8.20
- STTK $1.68
- Resistance Level
- PRE $10.79
- STTK $2.04
- Average True Range (ATR)
- PRE 0.73
- STTK 0.19
- MACD
- PRE 0.25
- STTK 0.09
- Stochastic Oscillator
- PRE 80.19
- STTK 89.29
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.